Pharming Group N.V.
PHAR
$16.24
$0.030.15%
NASDAQ
| 06/30/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | ||
|---|---|---|---|---|---|
| Net Income | -- | -12.26% | 19.19% | 18.84% | |
| Total Depreciation and Amortization | -- | 0.65% | -1.16% | 10.64% | |
| Total Amortization of Deferred Charges | -- | -3.62% | 22.78% | 22.78% | |
| Total Other Non-Cash Items | -- | 1,231.55% | 1,077.73% | 437.95% | |
| Change in Net Operating Assets | -- | 40.62% | 61.54% | -269.77% | |
| Cash from Operations | -- | 89.63% | 101.91% | 60.40% | |
| Capital Expenditure | -- | 45.02% | 32.96% | 54.38% | |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | |
| Divestitures | -- | -- | -- | -- | |
| Other Investing Activities | -- | 125.33% | 130.91% | 63.31% | |
| Cash from Investing | -- | 124.44% | 129.79% | 63.09% | |
| Total Debt Issued | -- | -- | -- | -- | |
| Total Debt Repaid | -- | -3,579.46% | -2,949.46% | -3,103.71% | |
| Issuance of Common Stock | -- | -41.24% | -64.05% | 359.21% | |
| Repurchase of Common Stock | -- | -- | -- | -- | |
| Issuance of Preferred Stock | -- | -- | -- | -- | |
| Repurchase of Preferred Stock | -- | -- | -- | -- | |
| Total Dividends Paid | -- | -- | -- | -- | |
| Other Financing Activities | -- | 3.00% | 15.24% | -36.74% | |
| Cash from Financing | -- | -3,212.03% | -12,929.34% | -284.80% | |
| Foreign Exchange rate Adjustments | -- | -203.81% | -91.55% | -110.92% | |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | |
| Net Change in Cash | -- | 95.33% | 104.48% | 31.85% | |